<DOC>
	<DOCNO>NCT02080247</DOCNO>
	<brief_summary>A randomize control trial compare use two topical zinc oxide base diaper rash product structure care regimen treatment IAD hospitalize adult old child .</brief_summary>
	<brief_title>Treatment Incontinence Associated Dermatitis Older Children Adults</brief_title>
	<detailed_description>Patients IAD recruit Philippine General hospital participate randomize control trial two topical zinc oxide base diaper rash product use part structure care regimen . All patient recruit either arm trial receive structured care regimen treatment IAD six day follow study entry . At least twice daily require incontinence episode , treatment care provide nurse nurse aid train study regimen ensure consistent implementation . Wet soil diaper remove affected area gently cleanse . Vigorous cleaning avoid . A thin layer study topical ointment apply prior put new diaper . Packs contain material require prepared patient daily , include brand diaper patient , skin cleanse product material , assign study ointment . Data collect day relate IAD use Kennedy Skin Condition Assessment Scale .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<mesh_term>Zinc Oxide</mesh_term>
	<criteria>Participant next kin/parent/guardian agree study inclusion sign inform consent form assent form accord detailed guidance consent / assent section . Ages : child ( least 12 year old 18 year old ) adult ( 18 year old ) Participant incontinent* urine and/or feces concomitant Incontinent Associated Dermatitis ( IAD ) . ( *Including functional incontinence , whereby ability control micturition defecation intact , patient unable toilet normally due immobilization reason. ) . There reasonable expectation participant hospitalize least 7 day able complete study . ( NB Study Participant Withdrawal Criteria b Any participant discharge hospital attend physician completion study participation automatically withdraw study . Study participation circumstance lead delay participant 's discharge hospital. ) . Participant known allergy history adverse reaction ingredient either product topical preparation skin care product . Participant diagnosis IAD severity score great equal 3 determine investigator . Participant preexisting pressure ulcer stage 3 4 full thickness wound within study area Participant active dermatological condition , history recurrent dermatological condition , IAD , may affect heal IAD imply difficult heal IAD . Where uncertainty exist , Investigators arrange consultation Consultant Dermatologist Participant severe acute chronic medical condition trial participation may constitute risk may interfere medical care attend physician advises participation . Participant precede week treat systemic topical agent ( topical treatment IAD ) may affect IAD heal process ( example steroid ) . e. Participant know allergy previous adverse reaction ingredient either product . Participant diagnosis IAD severity score less 3 determined investigator .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>